Please provide your email address to receive an email when new articles are posted on . Patients with congenital heart disease and Fontan physiology had a high prevalence of chronic venous ...

These new codes will allow for improved clinical documentation, insurance reimbursement, and health system recognition of the unique and complex needs of patients living with Fontan physiology. "This ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Udenafil in adolescents after Fontan surgery did not significantly improve oxygen consumption at ...

FORT LEE, N.J., May 14, 2026 /PRNewswire/ -- Mezzion Pharmaceuticals, Inc., a late-stage rare disease biopharmaceutical company focused on therapies for patients with single ventricle congenital heart ...

Dr Julian Alexander Härtel and Dr Nicole Müller from the Department of Paediatric Cardiology at the UKB, who jointly led the study, with study nurse and coordinator Ute Baur. The researchers conducted ...

Of the thousands of children born each year with congenital heart defects, a small cohort have severe malformations of their cardiac chambers leading to a single ventricle physiology. The current ...

Melissa Lyle, MD: Hello, everyone. I am Melissa Lyle, cardiology fellow at Mayo Clinic. Today, we will be discussing the management of Fontan patients. I am joined by my colleagues, Dr Alexander Egbe ...

SEOUL, South Korea, April 16, 2025 /PRNewswire/ -- Mezzion Pharmaceuticals, a global leader in the development of therapies for patients with single ventricle heart disease, announces a transformative ...